Organ TransplantationKidney TransplantationTissue DonorsHeart TransplantationLiver TransplantationGraft RejectionKidneyGraft SurvivalImmunosuppressive AgentsTissue and Organ ProcurementKidney Failure, ChronicTransplantation, HomologousKidney DiseasesTransplantationTacrolimusLiving DonorsCyclosporineMycophenolic AcidTransplantsCadaverTime FactorsWaiting ListsImmunosuppressionDelayed Graft FunctionBK VirusTreatment OutcomePancreas TransplantationRetrospective StudiesPostoperative ComplicationsPolyomavirus InfectionsHistocompatibility TestingLung TransplantationIsoantibodiesKidney Function TestsCreatinineDirected Tissue DonationRisk FactorsGlomerular Filtration RateCytomegalovirus InfectionsKidney TubulesAntilymphocyte SerumFollow-Up StudiesDonor SelectionTransplantation ImmunologyBiopsyBone Marrow TransplantationImmunocompromised HostAcute Kidney InjuryHLA AntigensRenal DialysisBrain DeathProspective StudiesPrimary Graft DysfunctionHistocompatibilitySurvival RateIranSirolimusOrgan SizeCalcineurinMultiple Organ FailureIncidenceKidney CortexRenal InsufficiencyOrgan SpecificityComplement C4bAzathioprineHematopoietic Stem Cell TransplantationCohort StudiesTissue and Organ HarvestingBiological MarkersDrug Therapy, CombinationCytomegalovirusProportional Hazards ModelsSurvival AnalysisTransplantation ToleranceKidney NeoplasmsKidney GlomerulusNephrectomyOrgan of CortiRisk AssessmentBlood Group IncompatibilityGingival HypertrophyUreteral DiseasesKaplan-Meier EstimateAcute DiseaseDrug MonitoringGanciclovirDeathLymphoproliferative DisordersPrognosisGraft vs Host DiseasePolycystic Kidney DiseasesMultivariate AnalysisMice, Inbred C57BLRegistriesKidney Tubular Necrosis, AcuteLiver FailureChronic DiseasePostoperative PeriodLiver